Simcere Pharmaceutical Group Limited
SMHGF
$0.6486
-$0.0621-8.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.22M | 19.32M | 31.53M | 31.80M | -107.95M |
| Total Depreciation and Amortization | 10.63M | 10.68M | 10.21M | 10.30M | 10.13M |
| Total Amortization of Deferred Charges | 1.63M | 1.64M | 922.80K | 930.80K | 876.60K |
| Total Other Non-Cash Items | 11.19M | 11.25M | 16.90M | 17.05M | 176.84M |
| Change in Net Operating Assets | -5.95M | -5.97M | -- | -- | -63.76M |
| Cash from Operations | 36.73M | 36.91M | 59.56M | 60.08M | 16.13M |
| Capital Expenditure | -24.81M | -24.93M | -- | -- | -33.46M |
| Sale of Property, Plant, and Equipment | 3.48M | 3.50M | -- | -- | 8.19M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 2.37M | 2.38M | -- | -- | 3.46M |
| Other Investing Activities | -26.09M | -26.22M | -27.75M | -27.99M | 3.50M |
| Cash from Investing | -45.05M | -45.27M | -27.75M | -27.99M | -18.30M |
| Total Debt Issued | 128.34M | 128.34M | 498.01M | 498.01M | 297.87M |
| Total Debt Repaid | -145.38M | -145.38M | -607.03M | -607.03M | -183.26M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -143.12M | -143.12M | -200.87M | -200.87M | -120.02M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -27.91M | -28.04M | -- | -- | -29.03M |
| Other Financing Activities | 13.94M | 13.94M | 453.16M | 453.16M | 9.78M |
| Cash from Financing | -48.23M | -48.47M | 19.78M | 19.96M | -28.42M |
| Foreign Exchange rate Adjustments | 117.70K | 118.30K | 40.90K | 41.20K | 127.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.43M | -56.71M | 51.63M | 52.08M | -30.47M |